 |
 |

The Clinical Use of Clonidine in Abrupt Withdrawal From MethadoneEffects on Blood Prennssure and Specific Signs and Symptoms
Dennis S. Charney, MD;
David E. Sternberg, MD;
Herbert D. Kleber, MD;
George R. Heninger, MD;
D. Eugene Redmond, Jr, MD
Arch Gen Psychiatry. 1981;38(11):1273-1277.
Abstract
Clonidine hydrochloride was found to be effective in the treatment of methadone hydrochloride withdrawal. Under controlled inpatient conditions established to assess dosage guidelines and to examine specific signs and symptoms of withdrawal, 20 of 25 (80%) patients were able to withdraw completely from methadone by the end of a two-week period. In most patients, ten to 11 days of clonidine administration, with a peak mean dose of 16 µg/kg/day, resulted in a perceived reduction in symptoms compared with previous attempts to become opiate free. At these doses clonidine significantly reduced standing blood pressure without producing clinical problems. The withdrawal symptoms of anxiety, restlessness, insomnia, and muscular aching were most resistant to clonidine treatment and were reported by the majority of patients.
Author Affiliations
From the Clinical Research Unit (Drs Charney, Sternberg, Heninger, and Redmond) and the Substance Abuse Treatment Unit (Dr Kleber), Connecticut Mental Health Center, Department of Psychiatry, Yale University School of Medicine, New Haven.
Footnotes
Accepted for publication May 1, 1981.
Reprint requests to Connecticut Mental Health Center, Department of Psychiatry, Yale University School of Medicine, 34 Park St, New Haven, CT 06509 (Dr Charney).
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
Treating Opioid Dependence: Growing Implications for Primary Care
Krantz and Mehler
Arch Intern Med 2004;164:277-288.
ABSTRACT
| FULL TEXT
Cocaine and Amphetamine Attenuate the Discriminative Stimulus Effects of Naltrexone in Opioid-Dependent Rhesus Monkeys
Sell and France
J. Pharmacol. Exp. Ther. 2002;301:1103-1110.
ABSTRACT
| FULL TEXT
Pharmacologic Treatment of Heroin-Dependent Patients
O'Connor and Fiellin
ANN INTERN MED 2000;133:40-54.
ABSTRACT
| FULL TEXT
Rapid and Ultrarapid Opioid Detoxification Techniques
O'Connor and Kosten
JAMA 1998;279:229-234.
ABSTRACT
| FULL TEXT
Inhibition of Reinforcing Effects of Morphine and Motivational Aspects of Naloxone-Precipitated Opioid Withdrawal by N-Methyl-D-aspartate Receptor Antagonist, Memantine
Popik and Danysz
J. Pharmacol. Exp. Ther. 1997;280:854-865.
ABSTRACT
| FULL TEXT
Blunted Growth Hormone Response to Clonidine in Patients With Generalized Anxiety Disorder
Abelson et al.
Arch Gen Psychiatry 1991;48:157-162.
ABSTRACT
Behavioral and Physiologic Effects of Short-term and Long-term Administration of Clonidine in Panic Disorder
Uhde et al.
Arch Gen Psychiatry 1989;46:170-177.
ABSTRACT
Impact of Clonidine on Alcohol Withdrawal States
Stock
Arch Intern Med 1988;148:241-245.
ABSTRACT
Clonidine in Morphine Withdrawal: Differential Effects on Signs and Symptoms
Jasinski et al.
Arch Gen Psychiatry 1985;42:1063-1066.
ABSTRACT
Clonidine in Outpatient Detoxification From Methadone Maintenance
Kleber et al.
Arch Gen Psychiatry 1985;42:391-394.
ABSTRACT
Narcotic Bowel Syndrome Treated with Clonidine: Resolution of Abdominal Pain and Intestinal Pseudo-Obstruction
SANDGREN et al.
ANN INTERN MED 1984;101:331-334.
ABSTRACT
Clonidine and Naltrexone: A Safe, Effective, and Rapid Treatment of Abrupt Withdrawal From Methadone Therapy
Charney et al.
Arch Gen Psychiatry 1982;39:1327-1332.
ABSTRACT
|